Hong Kong at a glance
- Population
- 7.5 million 2025
- Life expectancy at birth
- 85.4 years, 2024
- People aged 65 and over
- 23.7 % of people, 2025
Updated
Reviewed by Vidhi Upadhyay
Hong Kong Biotin Supplements Market Industry Trends and Forecast to 2034: Segmented by (Form, Application, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$0.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $0.6 Mn | — | — |
| 2025 (base) | $0.7 Mn | +$0.0 Mn | — |
| 2026 (forecast) | $0.7 Mn | +$0.0 Mn | +6% |
| 2027 (forecast) | $0.8 Mn | +$0.0 Mn | +12.4% |
| 2028 (forecast) | $0.8 Mn | +$0.0 Mn | +19.1% |
| 2029 (forecast) | $0.9 Mn | +$0.0 Mn | +26.2% |
| 2030 (forecast) | $0.9 Mn | +$0.1 Mn | +33.8% |
| 2031 (forecast) | $1.0 Mn | +$0.1 Mn | +41.9% |
| 2032 (forecast) | $1.0 Mn | +$0.1 Mn | +50.4% |
| 2033 (forecast) | $1.1 Mn | +$0.1 Mn | +59.4% |
| 2034 (forecast) | $1.1 Mn | +$0.1 Mn | +68.9% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $0.7 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $1.1 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.0% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Form and application (see all) |
| Key players | Amway, Church & Dwight Co., Inc, Doctors Best, Jarrow Formulas Inc, GNC Holdings Inc and 5 more (see all) |
| Regulator in Hong Kong | Drug Office and Centre for Food SafetySource: Drug Office, Department of Health. Checked 14 Nov 2026.Source: Centre for Food Safety. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Biotin supplements, also known as vitamin B7 or vitamin H, are dietary products designed to provide an essential nutrient that plays a critical role in various bodily functions, including the metabolism of carbohydrates, fats, and proteins. Biotin is vital for maintaining healthy skin, hair, and nails, and it supports the nervous system and energy production. While biotin deficiency is rare, supplementation is often sought for its potential benefits in promoting hair growth and improving nail strength.
Globally, the scenario for biotin supplements reflects a growing interest in health and wellness among consumers. Research indicates that many individuals use biotin to address concerns related to hair loss and brittle nails. For instance, a survey showed that approximately 30% of women in the U.S. reported using biotin supplements for hair health. Additionally, the rise of social media and beauty influencers has contributed to increased awareness and demand for biotin products. Despite the popularity of these supplements, scientific evidence supporting their effectiveness in individuals without a deficiency remains limited. The recommended daily intake of biotin for adults ranges from 30 to 100 micrograms. However, while adoption rates are high, concerns about product quality and the need for regulatory oversight persist, emphasizing the importance of informed consumer choices regarding supplementation.
The scenario for biotin supplements reflects a growing interest in health and beauty among consumers. Research indicates that many individuals use biotin to address concerns related to hair loss and brittle nails. For example, a study published in the Journal of Clinical and Aesthetic Dermatology found that biotin supplementation can significantly improve hair thickness and nail strength. Additionally, the rise of social media influencers promoting beauty products has contributed to increased awareness and demand for biotin supplements. In the United States, it is estimated that around 30% of women report using biotin supplements for hair health
The forecasted rise in the geriatric population is an opportunity for the companies within this market to create novel products specifically catered for this market base. Additionally the rise in diseases and conditions associated with biotin deficiencies, particularly skin and hair conditions is an opportunity for corporations within this market to use educational campaigns to educate consumers and also increase the sale of biotin-containing products. The increase in funding of R&D is an opportunity for the creation of new products to broaden the reach of this market.
Despite the popularity of these products, there are on-going concerns about the regulation of dietary supplements and the need for consumer education regarding appropriate dosages and potential side effects. This emphasizes the importance of informed decision-making when considering biotin.
In September 2025, Earth’s Splendor donated a large amount of biotin supplements to charity in order to fight the biotin deficiency in Long Island, USA.
In March 2025, Pet Honesty introduced two new cat supplements which both contain biotin and are designed to improve the immunity of cats.
In June 2024, NOW Foods acquired SuperFoods, a family owned business in order to expand their portfolio of vitamins.
In April 2021, Nature’s Bounty was acquired by Nestle as part of a large multi-million deal. This was done in order to increase Nestle's portfolio within the supplements and health and wellness industry.
Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health.[1] Health supplements are generally regulated as food, overseen by the Centre for Food Safety; proprietary Chinese medicines must be registered with the Chinese Medicine Council.[2]
[1] Drug Office, Department of Health. Checked 14 Nov 2026.
[2] Centre for Food Safety. Checked 14 Nov 2026.
Biotin is considered a dietary supplement in most regions, so it must meet the safety requirements, labelling standards and product certifications set out by the various regulatory bodies. Although laws around dietary supplements may be similar across continents, they are not identical and this makes launching products simultaneously in different countries difficult. Additionally all health claims made about biotin supplements must be substantiated by scientific proof in order for companies to get approval to launch their products. This has proven to be a difficult task for most companies as there is a lack of scientific research that backs up the health claims surrounding biotin supplementation. As businesses within this market are actively adjusting to accommodate consumer preferences they must adhere to the new regulations set in place in the post-pandemic era.
What doctors and scientists are doing in Biotin Supplement right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
From our blog
Hong Kong · 2 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 2 shared keywords
Hong Kong · 1 shared keyword
Pharmaceuticals · Hong Kong
Medical Devices · Hong Kong
Digital Health · Hong Kong
Healthcare Services · Hong Kong
Pharmaceuticals · Hong Kong
Pharmaceuticals · Hong Kong